Methods used to quit vaping among adolescents and associations with perceived risk, addiction, and socio-economic status.


Journal

Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486

Informations de publication

Date de publication:
12 2023
Historique:
received: 10 04 2023
revised: 07 08 2023
accepted: 15 08 2023
medline: 8 9 2023
pubmed: 21 8 2023
entrez: 20 8 2023
Statut: ppublish

Résumé

Despite widespread evidence suggesting that e-cigarettes are harmful to youth, the prevalence of adolescent vaping continues to rise. The first aim of this cross-sectional study was to determine which methods adolescents have previously used to quit vaping and their interest in using various methods to quit vaping in the future. The second aim was to investigate the associations between vaping-related characteristics and (1) motivation to quit vaping and (2) previous use of pharmacological methods to quit vaping or previous use of unassisted quitting. Participants were 185 current or former vapers, aged 14-19 (M age = 16.9 years, SD = 1.1; 52% female), recruited online from different U.S. regions. Data were collected through online questionnaires. Most participants reported at least one prior attempt to quit vaping (81.3%). Unassisted quitting was the most prevalent method to quit vaping (78.4%), followed by "advice from a friend" (51.9%). Participants were interested in using a variety of methods for quitting vaping in the future, including medication (28.8%), and mobile apps (34.6%). Greater perceived harm of vaping was significantly associated with motivation to quit vaping, while greater perceived risk of addiction and higher SES were significantly associated with lifetimeuse of nicotine replacement to quit vaping. Adolescents may be open to trying methods to quit that are different from what they have used previously. These findings could help direct resources toward the development of vaping cessation programs that are acceptable to adolescents.

Identifiants

pubmed: 37598643
pii: S0306-4603(23)00230-7
doi: 10.1016/j.addbeh.2023.107835
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107835

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The study was funded by The American Heart Association to B. Borrelli. (20YVNR35500014)

Auteurs

Emily Jones (E)

Center for Behavioral Science Research, Boston University Henry M. Goldman School of Dental Medicine, USA.

Romano Endrighi (R)

Center for Behavioral Science Research, Boston University Henry M. Goldman School of Dental Medicine, USA.

Daniel Weinstein (D)

Center for Behavioral Science Research, Boston University Henry M. Goldman School of Dental Medicine, USA.

Alexis Jankowski (A)

Center for Behavioral Science Research, Boston University Henry M. Goldman School of Dental Medicine, USA.

Lisa M Quintiliani (LM)

Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, USA; Section of General Internal Medicine, Boston Medical Center, USA.

Belinda Borrelli (B)

Center for Behavioral Science Research, Boston University Henry M. Goldman School of Dental Medicine, USA. Electronic address: belindab@bu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH